Lactiplantibacillus plantarum/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases C-reactive protein concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Normalized percentage data revealed that GKK1 reduced the relative CRP inflammatory burden at 24 h compared to the placebo (118.72 ± 39.32% vs. 209.45 ± 72.90%, p < 0.001, 95% CI [−124.76 to −56.70], Cohen’s d = 1.549) and maintained significantly lower absolute CRP levels through 48 h (p < 0.001, Cohen’s d = 1.873) (Table 6 and Figure 4C).”
Quoted verbatim from Effect of Lactiplantibacillus plantarum GKK1 Supplementation on Exercise-Induced Fatigue, Muscle Damage, and Recovery in Healthy Men: A Randomized, Double-Blind, Placebo-Controlled Trial.. - Study
- RCT
- Duration
- 4 weeks
- Dose
- two capsules daily, 1.0 x 10^11 CFU per day, 28 days before the damaging exercise
- Population
- Healthy sedentary adult men after a 100-jump plyometric muscle-damage protocol; relative change at 24 h and absolute level through 48 h post-exercise; placebo capsules in the comparator arm
Effect of Lactiplantibacillus plantarum GKK1 Supplementation on Exercise-Induced Fatigue, Muscle Damage, and Recovery in Healthy Men: A Randomized, Double-Blind, Placebo-Controlled Trial.2026PMID:42738954Industry fundedPermalink
Keep reading
- Everything the graph holds on Lactiplantibacillus plantarum
- Every compound studied against C-reactive protein concentration
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45XA92VFBKMGJRYQ0JMKB23